ATOS icon

Atossa Therapeutics

93 hedge funds and large institutions have $102M invested in Atossa Therapeutics in 2021 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 28 increasing their positions, 26 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

0.34% less ownership

Funds ownership: 1.97%1.64% (-0.34%)

55% less capital invested

Capital invested by funds: $225M → $102M (-$123M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
93
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$35M
Puts
$15.6M
Net Calls
Net Calls Change

Top Buyers

1 +$5.02M
2 +$3.96M
3 +$3.48M
4
BlackRock
BlackRock
New York
+$2.31M
5
N
Nuveen
North Carolina
+$1.93M

Top Sellers

1 -$9.09M
2 -$7.04M
3 -$6.38M
4
Millennium Management
Millennium Management
New York
-$5.44M
5
Jane Street
Jane Street
New York
-$4.28M
Name Holding Trade Value Shares
Change
Change in
Stake
26
$378K
27
$378K
28
$310K
29
$298K
30
$295K
31
$287K
32
$268K
33
$254K
34
$240K
35
$224K
36
$211K
37
$209K
38
$206K
39
$199K
40
$180K
41
$177K
42
$163K
43
$156K
44
$150K
45
$133K
46
$121K
47
$108K
48
$104K
49
$97K
50
$93K